Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

Natural glutamate uptake inhibitors useful for memory disturbances

July 24, 1998

Beta-sheet breaker peptide potentially effective against amyloidosis in Alzheimer's disease

July 24, 1998

Genentech stroke study terminated due to inability to demonstrate clinical benefit

July 23, 1998

Zelapar receives approval recommendation in U.K.

July 23, 1998

Phase III clinical trial results with galantamine suggest novel mechanism of action

July 23, 1998

Nortran initiates phase II trials for local anesthetic

July 23, 1998

New series of neuroprotective compounds described by Nippon Chemiphar

July 23, 1998

Inhaled analgesic available for licensing from BTG

July 23, 1998

Neurogen's epilepsy compound advances through clinical trials

July 22, 1998

Patient dosing begins in phase Ib trial of stroke drug from NPS

July 22, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for March 13, 2026.
Brain’s hidden tau-clearing pathway uncovered
BioWorld Science
Researchers at INSERM and collaborators have identified hypothalamic tanycytes as mediators of tau clearance and shown that their structural and genetic...
News in brief
BioWorld Asia
BioWorld Asia briefs for March 10, 2026
MSD synthesizes α-synuclein PET agents
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has prepared and tested new positron emission tomography (PET) agents for binding and imaging α-synuclein (SNCA) for the diagnosis...
Muscarinic M4 receptor positive allosteric modulators described in Neurosterix patent
BioWorld Science
Neurosterix Pharma Sarl has divulged 3-cyclopropylpyrazole derivatives acting as muscarinic M4 receptor positive allosteric modulators. They are reported to be...